Regulators Warn Thailand Over Drug Pricing Policy

Law360, New York (August 10, 2007, 12:00 AM EDT) -- European Commission regulators have warned the government of Thailand over its use of compulsory licenses for certain medicines, claiming that the country's pricing policy may violate the rights of European patent holders.

EC trade commissioner Peter Mandelson sent a letter to the Thai government criticizing a proposal that, if implemented, would allow the country to force drug companies to sell pharmaceuticals at lower prices, the Financial Times reported on Thursday.

Mandelson's letter attacked a government policy stating that “if drug companies wish to do business in...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.